Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : VVUS: VIVUS INC. (NASDAQ) -- Ignore unavailable to you. Want to Upgrade?

To: RT who wrote (8891)	6/2/1998 11:34:00 AM
From: DaiS	Respond to of 23519

RT, My estimate that is that the running total of viagra repeats over viagra news is presently about 10%, same as last week, before it was lower, except first week >70%. It has to go up in as big way for PFE I think. If one script lasts a month, it looks to me that many many viagra users are not coming back. I don't think that Vivus needs divine intervention just yet, they need to promote not just muse and actis as products but promote good use of their product, need to counsel failures, point out that if muse is not great first time don't give up too easily. And the docs too - once they get it into their heads that muse is no good - it will be very very very difficult to change their minds - human nature. I got impression from your earlier messages that you might know Leland or know someone who does. Any chance of, you know, getting some snippets to encourage us. DaiS